Type 2 Diabetes

Type 2 diabetes, formerly called adult-onset or noninsulindependent diabetes, is the most common form of diabetes. People can develop type 2 diabetes at any age, even during childhood. This form of diabetes usually begins with insulin resistance, a condition in which fat, muscle, and liver cells do not use insulin properly. At first, the pancreas keeps up with the added demand by producing more insulin. In time, however, it loses the ability to secrete enough insulin in response to meals. People who are overweight and inactive are more likely to develop type 2 diabetes. Treatment includes taking diabetes medicines, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.

What is Type 2 Diabetes?

Type 2 diabetes is a common metabolic condition that develops when the body fails to produce enough insulin or when insulin fails to work properly, which is referred to as insulin resistance. Insulin is the hormone that stimulates cells to uptake glucose from the blood to use for energy.

Diabetes Mellitus Type 2 Pathophysiology

Type 2 Diabetes Symptoms

Type 2 Diabetes Diagnosis

Type 2 Diabetes Screening and Prevention

Type 2 Diabetes Treatment

Living With Type 2 Diabetes

Vitamin D and Type 2 Diabetes

Is a Plant-Based Diet Good for Type 2 Diabetes?

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

What is Insulin Resistance?

Insulin Resistance Pathophysiology

See more featured articles »

Causes of Insulin Resistance

Insulin Resistance Treatment

Insulin Resistance Diagnosis

Insulin Resistance Symptoms

Insulin Resistance and Parkinson's Disease

Does the Keto Diet Increase the Risk of Diabetes?

The Risks of Prediabetes

What is Diabetes?

Fibromyalgia and Diabetes

Diabetes in Men versus Women

Insulin Medication

Latest Type 2 Diabetes News and Research

Your unique microbiome may be used to improve and personalize your future medical experience

Study explores the potential of microbiomes in personalized medicine, focusing on diagnostics, precision therapy, and the challenges in implementing microbiome-based interventions.

27 Dec 2023

Jersey Shore's bariatric surgery program earns accreditation for adult and adolescent care

Patients seeking surgical treatment for obesity and its related conditions in New Jersey have a high-quality choice for receiving care at a nationally accredited program that meets the highest patient safety and quality standards.

22 Dec 2023

Hederasaponin C may be a protective measure and novel therapeutic strategy for diabetic nephropathy

Announcing a new publication for Acta Materia Medica journal. There is great demand for the development of novel efficient therapeutic strategies or preventative measures to alleviate the life-threatening complications of type 2 diabetes.

21 Dec 2023

Dietary shifts to less processed foods significantly lower triglycerides in women

A Nutrients journal study models the impact of dietary changes on triglyceride levels in women of reproductive age, showing significant reductions with increased intake of minimally processed foods and omega-3-rich foods.

20 Dec 2023

Shattering myths: Study reveals new insights on type 1 diabetes and obesity link

Review examines the relationship between type 1 diabetes and weight disorders, debunking myths about T1D and offering recommendations for future research and therapeutic interventions.

18 Dec 2023

From diabetes drug to anti-inflammation powerhouse: The unexpected evolution of GLP-1

Research pioneer Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named 2023 breakthrough of the year by the Science Magazine.

18 Dec 2023

Study reveals higher post-meal insulin responses linked to lower diabetes risk over five years

Study investigated the long-term cardiometabolic effects of postprandial insulin hypersecretion in pregnant women, finding that higher insulin responses post-meals were linked to better beta-cell function and lower glucose levels, with reduced risk of pre-diabetes or diabetes over a 5-year period.

17 Dec 2023

Late-night eating linked to higher cardiovascular disease risk, study suggests

Study finds that the timing of meals, particularly late-night eating, is associated with an increased risk of cardiovascular disease, highlighting the importance of meal timing for cardiometabolic health.

17 Dec 2023

Study supports limiting red meat intake for type 2 diabetes prevention, highlights alternative protein sources

Study finds that consumption of red, processed, and unprocessed meat significantly increases the risk of type 2 diabetes, suggesting the benefits of substituting meat with nuts, legumes, and dairy.

17 Dec 2023

Metabolic syndrome linked to higher pancreatic cancer risk, study shows

Study finds a significant association between metabolic syndrome and an increased risk of pancreatic cancer, highlighting the importance of MetS prevention and management.

17 Dec 2023

New AI framework can rapidly identify new use cases for existing therapeutics

Scientists at Klick Applied Sciences have created an artificial intelligence framework that can rapidly identify new use cases for existing therapeutics, according to findings presented Friday at the NeurIPS conference that could greatly improve the drug repurposing process and transform the pharmaceutical industry.

15 Dec 2023

U.S. adults get a third of daily added sugar from snacking, research shows

Snacks constitute almost a quarter of a day's calories in U.S. adults and account for about one-third of daily added sugar, a new study suggests.

15 Dec 2023

School holidays are the prime time for excessive weight gain in Australian children

With summer holidays only weeks away, Aussie kids are looking forward to some well-deserved time off. But too much downtime could create health problems, as new research shows that holidays are the prime time for excessive weight gain in kids.

15 Dec 2023

How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.

14 Dec 2023

Atezolizumab plus carboplatin: A winning combination for metastatic triple-negative breast cancer

Immunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastatic breast cancer.

14 Dec 2023

High insulin response can be your health ally, study says

Researchers at Sinai Health have unearthed vital information about the relationship between insulin levels after eating and long-term heart and metabolic health.

13 Dec 2023

Study uncovers shift from cigarettes to vapes among pregnant teens with mixed impact on newborns' health

Study analyzed data from over 10,000 pregnant American teenagers to explore the impact of smoking cigarettes, vaping, or both on fetal health, particularly focusing on the likelihood of babies being small for gestational age (SGA). It revealed that cigarette use was associated with a higher risk of SGA, while no significant association was found between vaping and SGA.

13 Dec 2023